A paratyphoid fever combined vaccine (Yuxi Walvax biotechnology)
甲型副伤寒结合疫苗（玉溪沃森生物）
Report date: 2022/07/15 15:12:26
Base Information
Drug NameA paratyphoid fever combined vaccine (Yuxi Walvax biotechnology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWalvax Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesWalvax Biotechnology Co LtdYuxi Walvax Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A